ABSTRACT: The aim of the present paper is to expand the concept on how follicular selection takes place in the follicular phase of the natural menstrual cycle. It is suggested that inhibin-B exerts a more intimate role in this process than previously understood. Inhibin-B shows a peak in the circulation around cycle day 7, simultaneous with selection of the dominant follicle, whereas levels of estradiol and inhibin-A only start to increase a few days later suggesting that inhibin-B is mainly responsible for downregulating pituitary FSH release. New data now demonstrate that the circulatory peak of inhibin-B is reflected by peak production of inhibin-B, in contrast to inhibin-A, in the selected follicle with a diameter of 10-12 mm, where concentrations are one thousand times higher than in the circulation. This high inhibin-B concentration also exerts paracrine effects, stimulating theca cell androgen production in concert with LH. New data now suggest that in the corresponding granulosa cells androgens upregulate FSH receptor (FSHR) and LH receptor (LHR) mRNA expression, which in turn stimulate CYP19a mRNA expression providing the follicles which most effectively undertake these processes with the best chance of becoming selected. Inhibin-B production is stimulated by FSH and it appears that the acidic isoforms of FSH induce inhibin-B secretion most efficiently thereby, for the first time, placing the changing FSH isoform profile during the follicular phase in a physiological context. Collectively, it appears that inhibin-B is an integral part of follicular selection in the normal menstrual cycle, exerting both endocrine and paracrine effects and facilitating continued growth of the selected follicle.
Introduction
Prior to the IVF era, almost three decades ago, the follicular phase of the natural menstrual cycle was considered to consist of two phases, the first lasting around 7 days and the second lasting until ovulation, with a duration in most cases of around 5-7 days (Yen, 1978) . This contrasts the current view where the follicular phase is rather considered as one entity. Selection of the dominant follicle, carrying the potential for ovulation in any given menstrual cycle, was the event separating the first from the second part of the follicular phase. The dominant follicle is most often selected on cycle day 7 with more than two-thirds of all cycles having follicular selection accomplished from cycle day 6 to 9 (Fauser and Van Heusden, 1997) . The aim of the present paper is to expand on the detailed understanding of the hormonal regulation of follicular selection and to introduce a new mechanism involved in follicular selection during the human natural menstrual cycle. For the first time, inhibin-B secreted by granulosa cells is proposed as an important hormone in the process of follicular selection.
Hormonal characteristics of the follicular phase in the normal menstrual cycle
The hormonal profiles of the natural human menstrual cycle, including variations in inhibin-A and inhibin-B, are well known ( Fig. 1) (Groome et al., 1996) . The inter-cycle reduction in estradiol (E 2 ), progesterone and inhibin-A due to the demise of the corpus luteum removes pituitary downregulation and allows FSH to rise in the early follicular phase to surpass the threshold levels for follicular recruitment. A cohort of follicles, with diameters ranging from 2 to 6 mm, is thereby stimulated. Only one will become the follicle selected and destined for ovulation. At around the time of selection (i.e. cycle day 7), levels of FSH have already peaked and started to decline, with a continued slow decline towards ovulation (Fig. 1) . Meanwhile levels of LH remain relatively constant throughout the follicular phase with average levels around 4-6 IU/l. In connection with follicular dominance, aromatase expression becomes upregulated in the selected follicle destined for ovulation and E 2 secretion starts to increase (Yding Andersen et al., 2010) . However, the concentration of E 2 in circulation remains relatively unaffected from basal levels and starts to increase 2-3 days prior to ovulation (Groome et al., 1996) . The concentration of progesterone remains low during the entire follicular phase of the natural menstrual cycle except for just prior to ovulation when the dominant follicle produces large amounts of progesterone that plays a role in initiating the mid-cycle surge of gonadotrophins (Groome et al., 1996; Mahesh, 2012) .
The general view is that FSH becomes down regulated in the follicular phase of the natural cycle when the selected follicle starts to secrete primarily E 2 , which then exerts a pituitary feedback downregulation. However, there appears to be a spatial-temporal issue with this explanation since FSH levels start to decline several days before circulating levels of E 2 start to increase ( Fig. 1) (Groome et al., 1996; Welt et al., 1999a; Schneyer et al., 2000) . It is clear that levels of E 2 within the follicle (i.e. follicle fluid) only slowly start to increase around the time of follicle selection (Westergaard et al., 1986; Yding Andersen et al., 2010) , but this is only manifested in the circulation after a few more days.
Potential effect of inhibin-B in lowering circulating FSH levels
The other hormones known to affect pituitary downregulation of FSH release are inhibin-A and inhibin-B. The concentration of the two types Figure 1 Hormonal characteristics of the natural menstrual cycle in women. Reprinted with permissions from Groome et al. (1996). of inhibin demonstrates pronounced differences in circulation: The concentration of inhibin-A is only a fraction of that of inhibin-B, and the concentration shows a gradual increase towards ovulation. In contrast, inhibin-B exhibits a peak in the mid-follicular phase, which has been documented in several studies ( Fig. 1) (Groome et al., 1996; Welt et al., 1999a; Schneyer et al., 2000) . The peak of inhibin-B appears to occur 1 or 2 days after the FSH peak. This suggests that inhibin-B, rather than E 2 and inhibin-A, which are only rising later, is playing an important role securing FSH downregulation during the mid-follicular period in which follicular selection takes place (Welt and Schneyer, 2001) .
The active role of inhibin-B in affecting FSH release has been documented in women. In reproductive aged women it is well known that FSH starts to rise before changes in E 2 secretion are detected (Welt et al., 1999b) . Based on daily blood samples over the menstrual cycle, a group of younger women (i.e. <35 years of age) was compared with a group of older women (i.e. 35-46 years of age) (Welt et al., 1999b) . It was found that mean inhibin-B level was around 20% lower in older cycling women, while FSH and E 2 increased, and concluded that an attenuated negative feedback from inhibin-B is the most important factor controlling the earliest increase in FSH with aging, potentially showing that a decrease in inhibin-B is the earliest marker of the decline in follicle number with reproductive aging.
Support for an important role of inhibins in regulating FSH secretion has also been reported in younger subfertile patients with elevated circulating levels of FSH in the early follicular phase as compared to agematched controls (de Koning et al., 2008) . In women who maintain high levels of FSH for two consecutive cycles both inhibin-A and inhibin-B were lower during the early follicular phase, while women who had normalized FSH levels on cycle day 3 subsequent to elevated FSH levels showed normalized levels of inhibin-B in the preceding luteal phase (de Koning et al., 2008) .
Collecting daily blood samples across one menstrual cycle and a subsequent cycle in which selective oestrogen blockade with tamoxifen was administered, Welt and co-workers (2003) evaluated the influence of E 2 , inhibin-B and inhibin-A on FSH levels. Collectively, the results suggested that inhibin-B and inhibin-A played a more pronounced role in regulating FSH secretion during the follicular phase of the cycle, whereas E 2 was more important than the inhibins in regulating FSH release during the luteal phase and the luteal-follicular transition (Welt et al., 2003) .
Regulation of inhibin-B secretion in the developing human antral follicle
Inhibin-B is a granulosa cell specific hormone, which is secreted from developing follicles. Thus, circulating concentrations usually reflect follicular synthesis. Inhibin-B is accumulated in the follicular compartment and some is released to circulation. Therefore, an inhibin-B peak in the circulation during the mid-follicular phase is expected to be reflected in the follicular fluid content of the cohort of follicles present at that stage and especially in the newly selected dominant follicle. Using follicular fluid samples collected only during the natural menstrual cycle (without exogenous FSH stimulation) the intrafollicular concentration of inhibin-B is shown in relation to follicular diameter across the follicular phase (Fig. 2) . Indeed, follicles with a diameter of 10-12 mm show peak concentrations of inhibin-B, exhibiting intrafollicular concentrations at least one thousand times higher than in the circulation (Fig. 2) . Intrafollicular concentrations of inhibin-A only account for a fraction of that of inhibin-B and only start to rise after follicular selection (Fig. 2) . Further, the total follicular content of inhibin-B (concentration × volume) in these follicles also shows a pronounced peak at diameters of 10-12 mm (Fig. 3) with only minor contributions from follicles less than 6 to 7 mm in diameter. This is contrast to inhibin-A, which shows a gradual increase and a total content much lower than inhibin-B until after follicular selection. This suggests that the follicle is active in secreting inhibin-B and that circulatory concentrations of inhibin-B are predominantly influenced by the selected developing follicle with a diameter of 10-12 mm and confirms that secretion of the two inhibin subunits is differently regulated. This suggestion fits nicely with the observations in reproductive aged women as discussed above, where circulating levels of inhibin-B were reduced only by around 20% when the pool of recruitable follicles becomes reduced with age (Welt et al., 1999b) .
Granulosa cell synthesis of inhibin-B is under regulation by FSH suggesting a classical hormone feedback loop, in which FSH stimulates the secretion of hormones that inhibit its release from the pituitary. Structurally, FSH is a heterodimer (as are LH and TSH) that includes two peptide chains non-covalently linked; an α-peptide (common to all gonadotrophins) and a β-peptide (specific to each gonadotrophin, and that control the biological activity). Each of the two peptides is glycosylated and the composition of the four attached oligosaccharides differs profoundly (Timossi et al., 2000; Barrios-De-Tomasi et al., 2002) . This is the result of post-translational processing during synthesis in the pituitary gland. Thus, FSH exists as a family of iso-hormones in which the glycosylation or the oligosaccharide structures differ on a constant peptide backbone. The FSH isoform profile has been shown to play an important role in the bioactivity of the hormone (Yding Vitt et al., 2001; Nayudu et al., 2002) . In particular, the number of negatively charged sialic acid residues attached in the terminal position of the oligosaccharide residues creates heterogeneity in the electric charge, resulting in variability in the isoelectric point (i.e. the pH at which the molecule exhibits a net charge of zero) (Lombardi et al., 2013) . More acidic FSH isoforms (i.e. isoforms where the net charge is zero at relatively low pH values) exhibit a prolonged in vivo half-life as the higher number of sialic acid residues shields galactose residues and prevents hepatic asialoglycoprotein receptors from removing proteins from circulation and the lower isoelectric point also reduces kidney clearance. Regulation of pituitary release of specific FSH isoforms is governed by the selected follicle itself and is under control of circulatory concentration of E 2 (Padmanabhan et al., 1988; Wide et al., 2010) . E 2 downregulates pituitary expression of glycosyltransfereses, (e.g. 2,3 α-sialyltransferase), which are enzymes that catalyze the incorporation of sialic acid residues into the oligosaccharides side-chains attached to the FSH peptide backbone (Damian-Matsumura et al., 1999) . In accordance with this, the FSH isoforms released from the pituitary follow the E 2 pattern in the follicular phase with mainly acidic isoforms being secreted in the early/mid-follicular phase and a switch to less acidic FSH isoforms close to ovulation (Wide and Bakos, 1993; Anobile et al., 1998) .
The biological activity of the acidic and less acidic FSH isoforms also differ, with the less acidic isoforms being more active in promoting production of certain substances, including E 2 , cAMP, aromatase and tissue plasminogen activator, and in vitro follicular growth of rodent follicles, which has been documented in a number of different studies (Yding Andersen et al., 2001; Barrios-De-Tomasi et al., 2002) . In contrast, stimulation of α-inhibin gene expression, which is the peptide chain that is specifically incorporated into inhibin-A and inhibin-B, was surprisingly strongly upregulated by exposure to acidic FSH isoforms as compared to less acidic FSH isoforms in granulosa cells from rats (Timossi et al., 2000) . This shows that the different FSH isoforms have distinct signalling properties that permit FSH pleiotropic signals to be transduced effectively at the level of the FSH receptor (FSHR). Therefore, glycosylated variants of FSH behave as biased agonists that each may induce different responses within the granulosa cells (Arey and López, 2011) .
Taken together, the reduction in circulating FSH levels that occurs in the early/mid-follicular phase and which is essential in orchestration of mono-ovulation in women, is mainly regulated by the secretion of inhibin-B released predominantly by the selected follicle. The inhibin-B secretion is in turn stimulated by the action of FSH on granulosa cells and it appears that acidic FSH isoforms, which are secreted when E 2 levels are low, exert a specific physiological function in promoting inhibin-B secretion. The selected follicle also starts to show enhanced aromatase expression but to a lesser extent that inhibin-B secretion because acidic isoforms are less efficient in inducing aromatase expression. A few days prior to ovulation the increasing levels of E 2 in circulation affect the pituitary, which secretes higher amounts of less acidic FSH isoforms that further stimulate E2 secretion leading to ovulation of the mature oocyte.
Paracrine signalling of inhibin-B in the selected follicle during the natural menstrual cycle
The approximately one thousand times higher concentration of inhibin-B in the follicular compartment of the selected follicle as compared to circulation (Fig. 2) suggests that in the vicinity of the follicle the surrounding theca cells will be exposed to high concentrations of inhibin-B. Culture experiments with human theca cells have shown that LH induces androgen secretion (i.e. androstenedione). However, co-incubation with increasing concentrations of inhibin-B act dose-dependently in synergy with LH to increase androgen output up to around ten times (at an inhibin-B concentration of 100 ng/ml), which was the highest concentration tested (Hsueh et al., 1987; Hillier et al., 1991) . The measured 
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(27) (17) Figure 2 The average follicular fluid concentration of inhibin-B and inhibin-A (ng/ml) in relation to diameter of the follicle. The intrafollicular concentration of inhibin-B and inhibin-A was measured in follicular fluid aspirated from individual human small antral follicles in connection with removal of one entire ovary for fertility preservation, as previously described (Yding Andersen et al., 2010) . The preovulatory (i.e. follicle diameter 19 mm) follicular fluid was from women in their natural menstrual cycle who experience an endogenous mid-cycle surge of gonadotrophins . Inhibin-A was measured using a commercial ELISA kit (Ansh Lab. TX, USA). The volume was used to calculate the diameter assuming a spherical follicle. Data are mean ± SEM. Numbers in brackets show the number of follicle fluids analysed for each diameter.
concentration of inhibin-B in follicular fluid appears to peak at an average concentration of approximately 200 ng/ml making it conceivable that the theca cells in vivo actually will be exposed to concentrations in this range. In that case, an association between follicular fluid levels of inhibin-B and androstenedione/androgens would be expected, reflecting the in vivo situation. Indeed such an association is confirmed by a strong significant positive association between the follicular fluid concentrations of inhibin-B and testosterone/androstenedione in small antral human follicles of 3-12 mm in diameter (Yding Andersen et al., 2008) . Results of measurement of intrafollicular levels of androgen and inhibin-B and granulosa cell specific gene expression from a large number of normal human small antral follicles are presented in Table I (data not previously published). There are highly significant associations between intrafollicular levels of inhibin-B on one side and intrafollicular levels of androstenedione and testosterone, and between intrafollicular concentrations of inhibin-B and corresponding mRNA levels (assessed by RT-PCR) in the granulosa cells of FSHR, LH receptor (LHR) and CYP19a1, confirming and extending previous results (Yding Andersen et al., 2008) . Therefore, inhibin-B is likely to exert an important paracrine effect in vivo in securing androgen substrate for the cohort of follicles from which the selected one will be chosen.
In turn, the intrafollicular androgen levels are likely to induce augmented FSHR expression leading to increased LHR expression and subsequently increased aromatase (CYP19a1) expression, as previously suggested (Weil et al., 1998 (Weil et al., , 1999 Nielsen et al., 2011) . In addition, in this group of follicles the xpression of androgen receptor mRNA also positively associates, highly significantly, to FSHR and LHR gene expression (Yding Andersen et al., 2008; Nielsen et al., 2011) . Thus, gonadotrophin sensitivity becomes augmented and the selected follicle is in this way likely to achieve a developmental advantage compared to other follicles.
Taken together, through a paracrine signalling in the theca cells inhibin-B appears to stimulate androgen production and accumulation in the follicle-this in turn results in upregulation of FSHR and LHR expression making the follicle more sensitive to gonadotrophins, resulting in a higher likelihood of continued growth (Fig. 4) . The considerations in this section are based on associations and do therefore not necessary represent causative relations. Further studies, including mechanistic studies on how inhibins augment androgen output by the theca cells, will be needed to substantiate the proposed mechanisms.
Additional experimental evidence in support of a central role for inhibin-B in downregulating FSH secretion
A woman who presented with an inhibin-B secreting ovarian tumour showed anovulation and infertility (Krishnan et al., 2003) . The level of inhibin-B in circulation was 147 pg/ml while FSH was 0.8 IU/l. Levels of LH and E 2 were normal (6.7 IU/l and 129 pg/ml, respectively). The woman did not respond to clomiphene citrate stimulation. Following a unilateral salpingoophorectomy removing the tumour, levels of FSH returned to normal and the patient subsequently conceived and had a healthy baby (Krishnan et al., 2003) . Other studies have reported similar findings (Kurihara et al., 2004) . These case reports demonstrate that inhibin-B in concentrations around twice the peak concentration found in mid-follicular phase (around 75 versus 147 pg/ml) in vivo will suppress FSH secretion sufficiently to cause anovulation and once restored to physiological levels normal ovarian function will continue. These data enforce the notion of inhibin-B in vivo being an important regulator of pituitary FSH release.
If circulatory levels of inhibin-B are central in downregulation of pituitary FSH secretion, the opposite situation in which inhibin-B levels are reduced would potentially lead to augmented FSH secretion. Mice injected with antibodies against inhibin-B (thereby reducing circulating levels) react by development of multiple follicles as if they had been exposed to ovarian stimulation. Actually the mice produce almost twice as many mature oocytes as compared to the best results obtained with different regimes for administration of exogenous gonadotrophins (Wang et al., 2001) . After IVF more than twice the number of hatching blastocysts was observed in oocytes from animals receiving inhibin-B antibodies suggesting that in mice inhibin-B in vivo also shows pronounced effects on FSH release (Wang et al., 2001) . Testosterone (nmol/l) 310 155 ± 14 194 ± 18 290 ± 25 254 ± 17 r = 0.34; P < 4 × 10
FSHR (×1000) 181 124 ± 21 242 ± 58 256 ± 39 275 ± 114 r = 0.25; P < 0.001 LHR (×1000) 143 2.0 ± 0.8 2.5 ± 0.7 3.6 ± 1.3 9.1 ± 2.7 r = 0.35; P < 3 × 10
CYP19a1 (×1000) 147 19 ± 3 2 1 ± 7 3 9 ± 12 188 ± 43 r = 0.39; P < 2 × 10 −6 AR (×1000) 178 84 ± 17 123 ± 34 81 ± 17 66 ± 14 r = 0.05; P > 0.10
Data are expressed as mean ± SEM. FSHR, FSH receptor; LHR, LH receptor; AR, androgen receptor; CYP19a1, aromatase; CC, correlation coefficient Granulosa cells were collected according to Rosendahl et al. (2011) 
Inhibin-B and inhibin-A peaks during the mid-cycle surge of gonadotrophins
There is a peak of inhibin-B and a peak of inhibin-A release in connection with the mid-cycle surge of gonadotrophins. Therefore, the collective concentration of inhibins shows its highest circulatory concentration close to ovulation. There are no obvious explanations for this peak but it may be speculated that the inhibins are part of the mechanism for terminating the ovulatory FSH signal. In addition one other possibility exists because ovulation is also accompanied by a peak of androgen secretion (Judd and Yen, 1973; McNatty et al., 1976; Vermeulen and Verdonck, 1976) . It has been shown that the levels of testosterone rise by around 20% in connection with ovulation potentially increasing libido just when the fertilizable oocyte is present, thereby optimizing reproductive success. The ovulatory concentration of LH is high and it is conceivable that the high concentration of both inhibin-A and inhibin-B collectively exerts an important paracrine stimulus augmenting theca cell androgen output (as discussed above) that ensures the androgen rise in circulation.
The local ovarian effect of the increased androgen output could potentially enhance FSH sensitivity of the smaller follicles (as discussed above) and is a new argument on whether follicular recruitment occurs continuously throughout the menstrual cycle or whether two or three follicular cohorts or follicular waves are present during each cycle (-Baerwald et al., 2012) . The increased ovarian androgen output could potentially act in a paracrine manner augmenting FSHR expression by smaller follicles. If FSH sensitivity becomes increased and levels of FSH, which according to Groome and co-workers (1996) remain elevated at a level similar to that of the mid-follicular phase for a few days after ovulation, an additional cohort of follicles may be recruited, which, however, due to the declining FSH levels will not receive sufficient stimulation to reach the preovulatory stage. The declining levels of FSH during the luteal phase probably reflect a combined inhibitory effect of both E2 and the considerable peak of inhibin-A. During the luteal phase levels of inhibin-A reach a concentration around half of the peak level of inhibin-B during the follicular phase and, together with the relatively high levels of E 2 , may ensure that follicles do not reach the preovulatory size normally observed only beyond selection.
Structure and physiological impact of inhibin-B and inhibin-A on target cells
Structurally, both inhibins are heterodimers composed of two peptide chains covalently linked by a single disulphide bridge; an α-subunit (common to both inhibins) and a β-subunit that differs (β a specific to inhibin-A and β b specific to inhibin-B) (Makanji et al., 2011) . The two β-subunits share a 63% homology with neither one being glycosylated, in contrast to the α-subunit, which possesses two potential glycosylation sites (Makanji et al., 2007) . Both inhibins are released from granulosa cells as precursor forms that undergo proteolytic cleavage resulting in the 31-34 kDa forms present in the circulation depending on whether one or two oligosaccharides are attached (Antenos et al., 2007; Makanji et al., 2007) . As for gonadotrophins, the glycosylation of the inhibins has a major impact on the both the biological activity and the half-life of the molecules and is therefore important for overall net effect of the two hormones (Makanji et al., 2011) . It appears that the monoglycosylated form (i.e. Asn 268 ) is more potent that the di-glycosylated form (i.e. Asn 268 and Asn 302 ), which on the other hand has a longer half-life (Makanji et al., 2011) . The physiological actions of inhibins are undertaken by inhibiting the actions of the structurally related proteins, the activins (Bilezikjian et al., 1993) . Activin signal transduction is mediated via the surface receptors activin Type IB (ALK 4), Type IC (ALK 7), Type IIA and Type IIB (ActRIIA/B), which subsequently secures intracellular signal transduction mainly through the SMAD signalling system (Derynck and Zhang, 2003; Shi and Massague, 2003; Harrison et al., 2005) . The inhibins form high affinity complexes with the Type II receptors that of the dominant follicle in the human natural menstrual cycle. The proposed progressive sequence of events that lead to follicle selection are numbered 1-6; red arrows indicate inhibitory effects, whereas green arrows indicate stimulatory events: (1) In the early follicular phase, the pituitary secretes FSH (mainly acidic isoforms of FSH) due to low levels of estradiol (E 2 ), which are kept low by relatively high intrafollicular levels of anti-Mullerian hormone (AMH). Intrafollicular levels of AMH start to decrease at a follicular diameter of around 8 mm, slowly lifting the brake on E 2 production; (2) The predominantly acidic FSH isoforms stimulate inhibin-B secretion by the developing follicle and inhibin-B show a mid-follicular peak in both the circulation and in follicular fluid of follicles present at that time with a diameter of 10-12 mm; (3) The inhibin-B secreted exert two functions: first it downregulates pituitary FSH secretion and second it acts in synergy with LH locally to augment androgen output by the theca cells; (4) The androgens diffuse to the neighbouring granulosa cells and cause FSH receptor (FSHR) upregulation, that subsequently induce LH receptor (LHR) upregulation; (5) Increased numbers of LHR in particular, and also FSHR, result in increased E 2 output; (6) These events reduce pituitary FSH secretion even further, highlighting the physiological role of LH for follicular development in the second half of the follicular phase.
functionally antagonize the activin signalling. This inhibition is greatly enhanced when the inhibins form a complex with the co-receptor betaglycan, which enhances the affinity of inhibin-A for Type II receptors by up to 30 times (Makanji et al., 2011) .
It appears that inhibin-B is more potent that inhibin-A in reducing FSH release (Makanji et al., 2011) , which fits into the context of the new concept of an important role for inhibin-B in follicular selection, as suggested in the present review. The specific reason for this is unknown, but differences in glycosylation and the effect of the different forms of activin make it difficult to delineate the underlying mechanisms. Further it is intriguing that the concentrations of inhibins that exert endocrine effects in the pituitary occurs in the pg/ml scale, whereas the para and autocrine effects occurring in the theca and granulosa cells require the presence of concentrations in ng/ml scale. It has now been shown that a concentration of 100 ng/ml inhibin-A causes significant upregulation of the key enzymes in ovarian androgen production, namely CYP17 encoding 17a-hydroxylase and 3β-hydroxysteroid dehydrogenase (3β-HSD) in sheep (Young and McNeilly, 2012) , and previous studies found no paracrine effect of inhibin-A in the pg/ml scale (Hillier et al., 1991) . In contrast a reduction in FSH release appears to occur at inhibin-A concentrations below 100 pg/ml. In the future it will obviously be of importance to understand the mechanisms of actions in both situations.
Integrating inhibin-B as an important physiological hormone in follicular selection during the natural menstrual cycle
The data presented in this paper suggest that inhibin-B is an important physiological hormone in the selection of the dominant follicle during the follicular phase of the natural menstrual cycle, exerting both endocrine and paracrine effects. The inter-cycle decline in inhibin-A, E2 and progesterone reverse pituitary downregulation of FSH output and levels increase. In light of the low levels of E 2 , the pituitary output of FSH is composed primarily of isoforms with an acidic isoelectric pH, because E 2 prevents sialic acid residues from being incorporated into the four oligosaccharides attached to the FSH peptide. Less acidic FSH isoforms provoke a higher response in granulosa cells of most signalling pathways and hormones studied, as compared to acidic isoforms. However, acidic FSH isoforms provoke the formation of inhibin-B and inhibin-A in the granulosa cells of follicles with a diameter of 3-13 mm with high efficacy. As a consequence, a peak of inhibin-B occurs in the circulation around the mid-follicular phase. Inhibin-B is likely to be the main hormone securing reduced FSH secretion, which basically leads to mono-ovulation in women (Hillier et al., 1994; Yding Andersen and Ezcurra, 2011) . The continued presence of FSHR and the FSH-induced formation of LHR on the granulosa cells of the selected follicle subsequently lead to an increased E 2 output, which secures the dominance of the selected follicle and leads to a further reduction of FSH secretion and a shift towards less acidic FSH isoforms closer to ovulation.
In addition, inhibin-B acts as a paracrine hormone augmenting local theca cell androgen production through a synergistic stimulatory action with LH. The increased androgen production acts as a substrate for E 2 synthesis. In addition androgens will, via androgen receptors expressed in granulosa cells, locally augment FSHR and LHR expression. Thus the follicle in the recruitable cohort which best synthesizes inhibin-B under the influence of, primarily, acidic FSH isoforms will experience the highest androgen production in the theca cells and will subsequently become the follicle with the most FSHRs and LHRs. Therefore, this follicle will be best equipped to withstand the continued lowering of FSH levels and will consequently become the selected follicle for ovulation.
